AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

European Medicines Agency recommends suspension of marketing authorisations for sibutramine: Weight-loss medicine associated with increased risk of cardiovascular events to be removed from all markets in the European Union.

Chemical Business Newsbase

| January 22, 2010 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

The European Medicines Agency has finalised a safety review of medicines containing sibutramine. The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that the risks of these medicines are greater than their benefits and recommended the suspension of marketing authorisations for these medicines across the European Union. Sibutramine-containing medicines are authorised as Reductil, Reduxade, and Zelium and other trade names in the European Union. They are used to promotes weight-loss in obese patients and overweight patients who …

Related articles from newspapers, magazines, journals, and more
European Commission summary of European Union decisions on marketing...
News wire article from: Chemical Business Newsbase October 29, 2010 700+ words
Summary of European Union decisions on marketing authorisations in respect of...
News wire article from: Chemical Business Newsbase December 31, 2010 700+ words
Summary of European Union decisions on marketing authorisations in respect of...
News wire article from: Chemical Business Newsbase February 25, 2011 700+ words
Summary of European Union decisions on marketing authorisations in respect of...
News wire article from: Chemical Business Newsbase December 31, 2010 700+ words
Summary of European Union decisions on marketing authorisations in respect of...
News wire article from: Chemical Business Newsbase December 31, 2010 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily